Current and emerging medications for overweight or obesity in people with comorbidities

por Fujioka, K.
Publicado 2015

Effect of lorcaserin on weight reduction in persons with obstructive sleep apnea (OSA): a combined subgroup analysis from three randomized, controlled clinical trials

por Fujioka, K., Perdomo, C., Malhotra, M.
Publicado 2019

What weight loss treatment options do geriatric patients with overweight and obesity want to consider?

por MacMillan, M., Cummins, K., Fujioka, K.
Publicado 2016

Effect of lorcaserin in different age groups: a post hoc analysis of patients from the BLOOM, BLOSSOM and BLOOM‐DM studies

por Fujioka, K., Malhotra, M., Perdomo, C., Apovian, C. M.
Publicado 2019

Improvements in health‐related quality of life over 3 years with liraglutide 3.0 mg compared with placebo in participants with overweight or obesity

por Kolotkin, R. L., Gabriel Smolarz, B., Meincke, H. H., Fujioka, K.
Publicado 2017

Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion

por Halseth, A., Shan, K., Gilder, K., Malone, M., Acevedo, L., Fujioka, K.
Publicado 2018

Improvements in health‐related quality of life with liraglutide 3.0 mg compared with placebo in weight management

por Kolotkin, R. L., Fujioka, K., Wolden, M. L., Brett, J. H., Bjorner, J. B.
Publicado 2016

Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features.

por Hirano, T., Fujioka, K., Franzèn, B., Okuzawa, K., Uryu, K., Shibanuma, H., Numata, K., Konaka, C., Ebihara, Y., Takahashi, M., Kato, H., Auer, G.
Publicado 1997